Natera and Incyte partner on Phase II colorectal cancer trial
Natera and Incyte have entered into a clinical collaboration to conduct an interventional Phase II study of INCA33890 in colorectal cancer.
The post Natera and Incyte partner on Phase II colorectal cancer trial appeared first on Clinical Trials Arena .